Brief: Probiotec Ltd Sees FY21 Underlying EBTIDA Of $21 Mln To $22 Mln

Probiotec

09/06/2021 24:42

June 9 (Reuters) - Probiotec Ltd  PBP.AX :
    * FY21 UNDERLYING EBITDA GUIDANCE $21.0 - $22.0M
    * SEES FY211 GUIDANCE  RANGE FOR REVENUE $118 – $122M
    * EXPECT NSW SITE CONSOLIDATION STRATEGY TO BE MATERIALLY
ACCRETIVE FOR SHAREHOLDERS IN MEDIUM TERM
    * LATEST LOCKDOWN IN VICTORIA HAS HAD A MINOR NEGATIVE
IMPACT ON
GROUP’S FY21 EARNINGS

Source text for Eikon:  urn:newsml:reuters.com:*:nASX474r4m
Further company coverage:  PBP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))